Blue Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Blue Capital's PFE Position: Q3 2026 in Review
Blue Capital increased its Pfizer (PFE) stake by 3.9% in Q3 2026, buying an estimated $12K and bringing the position to 12,050 shares worth $344K. The position accounts for 0.21% of the portfolio, ranked #99.
Blue Capital first reported a position in PFE in Q4 2024 and has held it in 5 quarters since. The position peaked at $595K in Q4 2024. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Blue Capital held 12,050 shares of Pfizer worth $344K as of Q3 2026.
- Blue Capital bought 450 Pfizer shares in Q3 2026, an estimated $12K.
- Pfizer made up 0.21% of Blue Capital's portfolio in Q3 2026, its #99 holding.
- Blue Capital first reported a position in Pfizer in Q4 2024 and has held it in 5 quarters since.
- Blue Capital's Pfizer position peaked at $595K in Q4 2024.
- 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Blue Capital's 13F filing for Q3 2026, filed 13 Oct 2026.